List of Azurity Pharmaceuticals patents

Patents where

Current Assignee

Name

Azurity Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11918685 Amlodipine formulations	Patent 11918685 was granted and assigned to Azurity Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11918685	March 5, 2024
‌ US Patent 11142352 Apparatus and method for filling bulk materials into a container	Patent 11142352 was granted and assigned to Azurity Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11142352	October 12, 2021
‌ US Patent 11701326 Amlodipine formulations	Patent 11701326 was granted and assigned to Azurity Pharmaceuticals on July, 2023 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11701326	July 18, 2023
‌ US Patent 11517563 Liquid nimodipine compositions	Patent 11517563 was granted and assigned to Azurity Pharmaceuticals on December, 2022 by the United States Patent and Trademark Office.	Arbor Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11517563	December 6, 2022
‌ US Patent 11633478 Compositions and kits for Omeprazole suspension	Patent 11633478 was granted and assigned to Azurity Pharmaceuticals on April, 2023 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11633478	April 25, 2023
‌ US Patent 11771686 Compositions and kits for omeprazole suspension	Patent 11771686 was granted and assigned to Azurity Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11771686	October 3, 2023
‌ US Patent 11484498 Amlodipine formulations	Patent 11484498 was granted and assigned to Azurity Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11484498	November 1, 2022
‌ US Patent 11471409 Amlodipine formulations	Patent 11471409 was granted and assigned to Azurity Pharmaceuticals on October, 2022 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11471409	October 18, 2022
‌ US Patent 11103492 Compositions and kits for omeprazole suspension	Patent 11103492 was granted and assigned to Azurity Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11103492	August 31, 2021
‌ US Patent 11446246 Suspensions and diluents for metronidazole and baclofen		Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11446246	September 20, 2022
‌ US Patent 11324696 Suspensions and diluents for metronidazole and baclofen		Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11324696	May 10, 2022
‌ US Patent 11207307 Composition and method for proton pump inhibitor suspension	Patent 11207307 was granted and assigned to Azurity Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.	‌ Cutispharma, Inc.	Azurity Pharmaceuticals	United States Patent and Trademark Office	11207307	December 28, 2021
‌ US Patent 11364230 Amlodipine formulations	Patent 11364230 was granted and assigned to Azurity Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11364230	June 21, 2022
‌ US Patent 11638692 Composition and method for vancomycin oral liquid	Patent 11638692 was granted and assigned to Azurity Pharmaceuticals on May, 2023 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11638692	May 2, 2023
‌ US Patent 11478456 Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof		Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11478456	October 25, 2022
‌ US Patent 11529333 Oral pharmaceutical composition comprising zonisamide and process of preparation thereof	Patent 11529333 was granted and assigned to Azurity Pharmaceuticals on December, 2022 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11529333	December 20, 2022
‌ US Patent 10959947 Composition and method for vancomycin oral liquid	Patent 10959947 was granted and assigned to Azurity Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	10959947	March 30, 2021
‌ US Patent 10959948 Composition and method for vancomycin oral liquid	Patent 10959948 was granted and assigned to Azurity Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	10959948	March 30, 2021
‌ US Patent 10959949 Composition and method for vancomycin oral liquid	Patent 10959949 was granted and assigned to Azurity Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	10959949	March 30, 2021
‌ US Patent 10959946 Composition and method for vancomycin oral liquid	Patent 10959946 was granted and assigned to Azurity Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	10959946	March 30, 2021
‌ US Patent 11173141 Enalapril formulations	Patent 11173141 was granted and assigned to Azurity Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11173141	November 16, 2021
‌ US Patent 11141405 Enalapril formulations	Patent 11141405 was granted and assigned to Azurity Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11141405	October 12, 2021
‌ US Patent 12128083 Lisinopril formulations	Patent 12128083 was granted and assigned to Azurity Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	12128083	October 29, 2024
‌ US Patent 11911473 Compositions and kits for omeprazole suspension	Patent 11911473 was granted and assigned to Azurity Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11911473	February 27, 2024
‌ US Patent 11759457 Liquid nimodipine compositions	Patent 11759457 was granted and assigned to Azurity Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.	Azurity Pharmaceuticals	Azurity Pharmaceuticals	United States Patent and Trademark Office	11759457	September 19, 2023

Results per page:

25 results

0 selected

25 results

0 selected